Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Ohmachi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Endocrine Journal|December 27, 2021
Analysis of thyroid function in Japanese patients with coronavirus disease 2019Sachiko Nakamura, Nozomi Kido, Miki Watanabe, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2026
Metabolic and muscular effects of switching from somatropin to somapacitan in adults with growth hormone deficiencyYuka Oi-Yo, Shin Urai, Masaaki Yamamoto, et al.
Endocrine Journal|June 8, 2025
Body mass index and metabolic complications in individuals with treatment-naïve acromegalyNaoki Yamamoto, Shin Urai, Masaaki Yamamoto, et al.
Endocrine Journal|July 8, 2026
Real-world optimization of cutoff values for enzyme immunoassay-based plasma-free fractionated metanephrines for the diagnosis of pheochromocytoma and paraganglioma: a multicenter retrospective studyMasato Yonamine, Ryota Ishii, Katsutoshi Takahashi, et al.
Frontiers in Endocrinology|January 7, 2025
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndromeYasutaka Tsujimoto, Naoki Yamamoto, Hironori Bando, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitisHironori Bando, Masaaki Yamamoto, Shin Urai, et al.
Pituitary|September 19, 2024
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in JapanYuka Oi-Yo, Masaaki Yamamoto, Shin Urai, et al.
Frontiers in Endocrinology|January 23, 2023
Case report: Late middle-aged features of <i>FAM111A</i> variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-upYuka Ohmachi, Shin Urai, Hironori Bando, et al.
Journal of Neurosurgery|April 24, 2026
Molecular markers of Rathke's cleft cysts and their clinical correlates: insights from experimental and human analysesYuriko Sasaki, Hironori Bando, Maki Kanzawa, et al.
Endocrine|January 11, 2024
The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomasYuka Ohmachi, Masaaki Yamamoto, Yuiko Inaba, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine Journal|December 27, 2021
Analysis of thyroid function in Japanese patients with coronavirus disease 2019Sachiko Nakamura, Nozomi Kido, Miki Watanabe, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2026
Metabolic and muscular effects of switching from somatropin to somapacitan in adults with growth hormone deficiencyYuka Oi-Yo, Shin Urai, Masaaki Yamamoto, et al.
Endocrine Journal|June 8, 2025
Body mass index and metabolic complications in individuals with treatment-naïve acromegalyNaoki Yamamoto, Shin Urai, Masaaki Yamamoto, et al.
Endocrine Journal|July 8, 2026
Real-world optimization of cutoff values for enzyme immunoassay-based plasma-free fractionated metanephrines for the diagnosis of pheochromocytoma and paraganglioma: a multicenter retrospective studyMasato Yonamine, Ryota Ishii, Katsutoshi Takahashi, et al.
Frontiers in Endocrinology|January 7, 2025
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndromeYasutaka Tsujimoto, Naoki Yamamoto, Hironori Bando, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitisHironori Bando, Masaaki Yamamoto, Shin Urai, et al.
Pituitary|September 19, 2024
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in JapanYuka Oi-Yo, Masaaki Yamamoto, Shin Urai, et al.
Frontiers in Endocrinology|January 23, 2023
Case report: Late middle-aged features of <i>FAM111A</i> variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-upYuka Ohmachi, Shin Urai, Hironori Bando, et al.
Journal of Neurosurgery|April 24, 2026
Molecular markers of Rathke's cleft cysts and their clinical correlates: insights from experimental and human analysesYuriko Sasaki, Hironori Bando, Maki Kanzawa, et al.
Endocrine|January 11, 2024
The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomasYuka Ohmachi, Masaaki Yamamoto, Yuiko Inaba, et al.
Pageof 2